Many people with cancer experience dramatic loss of muscle and fat tissue. In many cases, even the heart muscle is affected, ...

British Journal of Cancer - A phase II study of paclitaxel and capecitabine as a first-line combination chemotherapy for advanced gastric cancer Skip to main content Thank you for visiting nature.com.

We compared the efficacy of two different taxanes, docetaxel and paclitaxel, given either weekly or every 3 weeks, in the adjuvant treatment of breast cancer.We enrolled 4950 women with axillary ly ...

On the basis of phase 2 studies, trastuzumab deruxtecan was approved for patients with human epidermal growth factor receptor 2 (HER2)–positive metastatic gastric cancer or gastroesophageal ...

December 27, 2007 — The addition of bevacizumab (Avastin, Genentech/Roche) to paclitaxel does not appear to prolong overall survival in women with metastatic breast cancer, researchers report in ...

Topline data were announced from a phase 2/3 trial evaluating tovecimig in combination with paclitaxel in patients with unresectable advanced, metastatic or recurrent biliary tract cancers (BTC).

It enrolled 1,336 patients with either non-small cell lung cancer, breast cancer, or ovarian/fallopian tube cancer who were receiving treatment with paclitaxel or docetaxel.

Meeting Coverage > GiCS Video Pearls CTX-009/Paclitaxel Yields Responses in Advanced Biliary Tract Cancer — High toxicity, however, needs to be addressed in future trials, says Paul Oberstein, MD ...

Keywords: Shikonin, Paclitaxel, Triple-negative breast cancer, Pyruvate kinase M2 (PKM2), Cancer stem-like cells, Vasculogenic mimicry, Tumor microenvironment, Albumin ...